sarcopenia
2 statements across 2 episodes · 1 bullish · 0 bearish · 2 people on the record · first statement Jan 17, 2019 by Vas Narasimhan · across every show →
Everything said about sarcopenia, oldest first
Jan 17, 2019 neutral
Novartis CEO: Novartis previously ran an internal aging program targeting sarcopenia
“You know, we had actually an aging program, a small aging program for some time where we were trying to work on things like sarcopenia, which is muscle wasting and similar, similar kinds of conditions. It turns out to be very, very difficult to, because again,…”
Nov 14, 2025 bullish
Nuzhna: A GLP-1-style race is emerging for muscle loss drugs
“I think muscle is in a similar space right now where for a while people weren't treating sarcopenia as a real indication because it's sort of muscle loss in elderly, but there is now a similar race to JLP wants to go and develop drugs for muscle.”